ASCO: Extension of Aromatase Inhibitor Tx Benefits Breast CA
Extension of aromatase inhibitor treatment to 10 years linked to higher rates of disease-free survival
More Evidence That Low-Dose Aspirin Ups Survival in CRC
Most benefit seen for those taking the drug before their cancer diagnosis
15.5 Million Americans Now Surviving Cancer
But better tools needed to support their long-term recovery, researchers say
Too Few Patients Receive Surgical Treatment for Ovarian Cancer
Advanced age, disease are predictors for receiving only chemo, radiation, or nothing at all
Patients Like to See Physicians Wearing White Coats
Patients prefer doctors who wear 'professional' attire, survey finds
AMA Module Promotes Training of Medical Assistants
Module contributed by medical group in New Jersey includes interactive learning, eliminates testing
Breast Cancer Survivors Benefit From Mindfulness Meditation
Six-week class reduced fear of recurrence, fatigue and anxiety, researchers report
HSCT No Better Than Chemo in Philadelphia-Negative ALL
For patients ≥40 years, HSCT linked to lower cumulative incidence of remission, worse mortality
May 2016 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for May 2016. This roundup includes...
Vigilance Urged for Heparin-Induced Thrombocytopenia
Heparin should be terminated on suspicion of HIT; alternative anticoagulants recommended
